ABSTRACT Smoking induced changes in the secretory cells of bronchiolar epithelium by facilitating secretion of cross linked glycoprotein mucus may influence the efficiency of mucus-cilia coupling. The functional impact on mucociliary transport in small (peripheral) airways has been studied by comparing data on aerosol deposition and clearance from symptomless cigarette smokers (30 tests, 18 subjects) with data from age matched non-smokers (30 tests, 19 subjects). Gamma camera images, assessed in terms of a penetration index comparing peripheral with inner zone deposition, indicated closely similar initial deposition in the two groups. Alveolar deposition, however, assessed in terms of particle retention at 24 hours, was significantly (p < 0.01) less in the smokers. Given the similarity of initial deposition, this implies that an increased proportion of small conducting airways are protected by mucociliary defence in the smokers' lungs. Clearance from conducting airways of the peripheral zone in tests with relatively high peripheral deposition (14 tests on smokers, and 12 on non-smokers) nevertheless proceeded at the same rate in smokers as in non-smokers.
Mucociliary transport is generally taken to be the basic mechanism that removes mucus and matter entrapped in it from the ciliated conducting airways. The effects of cigarette smoking on the cells and glands from which airways mucus originates cause qualitative and quantitative changes in the load placed on the mucociliary "escalator." These changes may in turn alter the efficiency of the mucus-cilia coupling, which transmits the driving force of that escalator.
The earliest pathophysiological effects attributable to smoking occur in the distal small airways.1 Despite this, no satisfactory evidence has been available on the effectiveness of mucociliary defence in the peripheral conducting airways of smokers' lungs. We now present data indicating a difference between smokers and non-smokers in the amount of mucus removed from peripheral airways but similarity in the rate at which mucus is removed from these airways.
Results from 30 tests of radioaerosol deposition and clearance carried out in symptomless cigarette smokers under the age of 50 were compared with those from 30 tests in healthy non-smokers of similar age. The tests concerned were drawn from several studies of mucociliary clearance carried out in our departments over the past five years. All subjects gave informed, written consent and the radioaerosol procedure has been approved by the ethical practices committee of the Royal Free Hospital. Pulmonary function was assessed by dry bellows spirometer (Vitalograph) 10-20 minutes before each radioaerosol inhalation and was compared with published predicted values.2 Each subject was asked to record any coughs (including throat clearings) during the first six hours after radioaerosol inhalation; most of the subjects were members of the hospital staff performing ordinary duties between times of attendance at the laboratory and so we recognise that some of their records of cough frequency may be incomplete.
The radioaerosol inhalation procedure3 comprised eight breaths of 450 ml volume taken from approximately functional residual capacity, each followed by a three second breath hold to encourage deposition by sedimentation in the more distal airways. A 524 29 (10) 32 (9) 31 (12) 31 (8) Cigarette consumption (pack y)
113 (16) 102 (12) 107 (12) 102 (11) MMP (Is-,)
101 (21) 93 (18) 90 (18) 93 (15) Radioaerosol inhalation flow rate (I min-') 32 (13) 35 (15) 26 (14) 33 ( ISignificant difference between smokers and non-smokers (p < 0.02).
MMF-maximal mid expiratory flow. being an arbitrary but reasonable choice).
Statistical comparisons between groups were performed with Student's t test, and analysis of covariance8 was used to test the difference in position between regression lines of similar slope.
Results
The groups of smokers and non-smokers were quite closely matched for age and lung function (table 1). The mean PI was closely similar in the two groups but AD was significantly (p < 0.01) less in smokers than in non-smokers; the relationship between PI and AD is illustrated in figure 2 . The two regression lines shown are similar in slope (non-smokers, 0.0094; smokers, 0.0090) but differ significantly in position (t = 3.7, p < 0.001), the mean PI corresponding to any given AD being about 0.1 higher in smokers than in non-smokers. The implication is that for any particular division of aerosol particles between deposition on the mucociliary escalator (100% -AD) and deposition not on the mucociliary escalator (AD), the mean particle deposition site-as seen by the gamma camera tends to be more peripheral in smokers than in non-smokers. Any given value of percentage particle deposition on the mucociliary escalator is associated with a higher ratio of outer to inner zone deposition in smokers than in non-smokers. At the Functional small airways defence in symptomless cigarette smokers Bronchiolar epithelium from smokers, on the other hand, readily secretes glycoproteins. 9 The smokers' bronchioles have much more abundant mucus cells (very few are found in non-smokers) and fewer Clara cells.20 23 The logical inference must be that a greater extent of bronchiolar protection by Liquid from the alveolar zone Mucus from the bronchioles 527 528 mucociliary transport is available to the smoker. The relationship we report between penetration index and alveolar deposition (fig 2) supports this proposition. In essence, we find the same initial gamma camera images in smokers as in non-smokers, with the same mean PI in the two groups (table 1); but our 24 hour clearance data show that more particles are cleared from the lung by mucociliary action in the smokers (mean AD 44%) than in the non-smokers (mean AD 55%). An enhanced deposition in the peripheral conducting airways of the smokers could in theory result from changes in airway calibre. Under the inhalation conditions used, however, bronchiolar deposition results from a mixture of impaction and sedimentation, 2 the former enhanced by constriction of the bronchioles and the latter by dilatation. Modelling studies suggest that large changes would be required for any appreciable effect: a 20% reduction of mean bronchiolar diameter is predicted to cause an increase of only a few percent in particle deposition in the bronchioles. 25 Histopathological data (from subjects somewhat older than ours), however, suggest that the mean bronchiolar diameter differs little between smokers and non-smokers.2i 26 Thus, as any direct mechanical effect on particle deposition seems unlikely, we argue that increased bronchiolar glycoprotein secretion in smokers really is translated into an enhanced mucociliary protection of the smokers' bronchioles-and that our data (fig 2) illustrate this functional, change.
By the same argument, the average distance for particle clearance from the initial deposition site to the trachea should be greater in smokers than in nonsmokers. This must contribute to the smokers' delayed tracheobronchial clearance, assessed in terms of clearance from the lung as a whole (fig 3) . Our present data do not, however, rule out the possibility of a further contribution from delayed transit through the larger bronchi. 27 When attention is focused on peripheral conducting airways (fig4), a minimal difference in clearance is apparent between smokers and non-smokers. This implies a well functioning mucociliary defence system in the smokers' small airways.
Other In vivo, however, coagulation, hygroscopic growth, and behaviour as a "dense smoke aerosol"35 all contribute to deposition and the effective size is uncertain. Nevertheless, total lung deposition of cigarette smoke under varying conditions ranges from 80% to 100%,34 which is similar to that occurring with 5 pm particles and far more than would be expected with 0.5 pm particles.36 Bronchiolar deposition of our test particles may therefore roughly parallel that of smoke particles.
Previous assessments (in most instances testing clearance from the larger bronchi rather than from peripheral airways) have presented conflicting results concerning clearance rates in symptomless smokers.27 3740 Peripheral clearance can be satisfactorily measured only when an adequate proportion of the test aerosol is deposited peripherally.4i In the present study this was ensured by analysing peripheral clearance only for tests in which there was a relatively high penetration index. It is therefore of some interest that our results differ from those recently reported by Foster etal,40 who found significantly prolonged peripheral retention in six young smokers with moderately high peripheral deposition (mean AD 45%); these smokers reported low cigarette consumption (< 5 pack years) and their aerosol deposition pattern was indistinguishable from that of age matched non-smokers. Our results may therefore represent a slightly later stage in the lung's response to smoking.
Our data on clearance emphasise the near normality of peripheral airways clearance rates in symptomless smokers with some 10-20 pack years of cigarette consumption. Our data on deposition (fig 2) are consistent with the proposition that the mucociliary escalator in such persons chronically has to carry a heavier load of mucus originating (in part) from peripheral secretion sites. It has been speculated that impaired mucociliary transport in "healthy" smokers may act as a pathogenetic factor in the development of airflow obstruction,3740 and clearance is generally accepted as being severely retarded in smokers who have developed chronic bronchitis.37 3942 Whether or not progressive changes in mucociliary transport have any pathogenetic role, they may well represent the breakdown of an overloaded clearance mechanism. This, rather than a slow rate of peripheral clearance per se, might play a part in some smokers' progression towards clinically
